insomnia-symposium-evaluation

Post meeting evaluation

Location: *

Others: *

Title: *

First Name: *

Last Name: *

Institute: *

Email Address: *

MCHK Registration Number (Mandatory for obtaining MCHK CME): *

CME Accreditation: *

1. What is your prescribing experience with lemborexant? *

If you have prescribed lemborexant before, would you now consider prescribing it to a wider variety of insomnia patients? *

If yes, please specify which types of patients. Tick all that apply. *

If no, why not? *

If you haven’t prescribed lemborexant before, do you now feel confident in prescribing it in the future? *

If yes, please specify which types of patients. Tick all that apply. *

If no, why not? *

2. Were the Asian sub-group analysis and local case studies relevant to your clinical management of insomnia patients? *

3. How has your confidence in switching from existing hypnotics to lemborexant improved? Rating from 1-4. *

4. What additional information would you like to have about DORAs/lemborexant? (Tick all that apply) *

Others (please specify) *

5. What topics would you like to learn more about at future meetings?